Souhaitez-vous accéder aux communiqués récents ?

SPR will feature three abstracts on chronic low back pain and the use of SPRINT PNS at the ASPN conference in Miami, July 16-19.

Long term data published indicated that 79 percent of participants in this SPRINT PNS survey avoided subsequent low back pain interventions.

SPR announce fifth consecutive Top Workplaces award, highlighting strong corporate culture and continued growth.

New data just published indicated that per protocol treatment delivery of SPRINT PNS was significantly associated with achieving meaningful pain relief.

SPR to feature eight abstracts on SPRINT PNS at the 2026 North American Neuromodulation Society (NANS) Annual Meeting in Las Vegas.

Clinical trial comparing 60-day PNS to standard interventions demonstrates superior pain relief for low back pain with SPRINT PNS.

SPR Therapeutics ranked first on the Crain’s Cleveland Business Fast 50 list of rapidly growing, privately held companies in Northeast Ohio.

Medical Device Leader SPR Therapeutics again named a Top Workplace in Northeast Ohio

Publication of study provides evidence of the impact of SPRINT PNS in relieving post-operative knee pain after total knee arthroplasty (TKA).

Publication of study provides evidence of the impact of SPRINT PNS in relieving post-operative knee pain after total knee arthroplasty (TKA).